Trelleborg to Expand its Manufacturing and BioPharma Capabilities
Linda Muroski, President of Trelleborg Healthcare & Medical, says: “The site will expand our manufacturing capacities of Class 7 and 8 cleanrooms by 25,000 ft2 to meet the market’s growing demand for biopharmaceutical applications, such as silicone tubing and hose, assemblies, and other integrated solutions.
“The investment is a key milestone in our global biopharmaceutical strategy and will enable us to expand our offerings to existing and new customers in the industry. Our customers need a global partner for growth, and we are committed to being that partner.”
The three-phase expansion project will bring capacities and capabilities online incrementally over the next 24 to 36 months, with phase one commencing in January 2023. This project follows the expansion of milling and extrusion capacities at the Northborough site earlier this year and is expected to create at least 50 new jobs.
Florance Veronelli, Global Business Development Lead for Biopharmaceutical, says: “The expansion will enable us to increase our manufacturing capacities for extrusion and molding and offer enhanced flexible manufacturing solutions. As a full-service provider to the biopharmaceutical industry, our value-added offering will include assembly, kitting, contract manufacturing, packaging, validation, supply chain management, and more.”
Trelleborg is known for supplying original equipment manufacturers and pharmaceutical companies with high-quality tubing and hose products, such as the highly reliable and sustainable PharmaTube™ platinum silicone tubing for single- and multi-use pharmaceutical applications. The company’s portfolio also includes a broad range of O-Rings, seals, bearings, and composite products.
For more information, please visit:
Press Service:
If you reproduce information from this release please give contact details as:
www.trelleborg.com
E-mail: news@trelleborg.com